Clinical trial
Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III…
NCT00006256 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006256 |
|---|---|
| Title | Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer |
| Official title | Concurrent Taxol (Paclitaxel) and Definitive Breast Radiation Therapy in Early Stage Breast Cancer Following Four Cycles of Adriamycin/Cytoxan Chemotherapy |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | paclitaxel, adjuvant therapy, radiation therapy |
| Enrollment | 44 |
| Start date | Jun 8, 2000 |
| Primary completion | Nov 30, 2005 |
| Completion | Nov 20, 2023 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 30, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: